Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CyberGene Aktiebolag
AB
Active
Org 5565045019
Banvaktsvägen 22, 171 48
Solna
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 1995
2 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
CyberGene Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
3M
4M
6M
3M
2021
4M
2022
4M
2023
4M
2024
5M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
3 361
4 293
4 404
3 933
5 252
Staff expenses
—
—
—
—
—
EBITDA
350
202
188
−469
1 065
Depreciation & amort.
−0
−14
−23
−23
−31
EBIT
350
188
165
−492
1 034
Net financials
−1
—
−8
13
—
Profit before tax
349
188
160
−479
1 035
Tax
−0
−0
−0
−0
−0
Net profit
349
188
160
−479
1 035
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
3 766
4 114
4 695
5 149
4 650
Equity
3 469
3 656
3 817
3 338
4 372
Long-term debt
0
0
0
0
0
Short-term debt
298
457
878
1 811
278
Total debt
298
457
878
1 811
278
Financial ratios
5-year trend
EBITDA margin
20.3%
This company
15.8%
Market median
+28% vs market
2021
2025
Equity ratio
94.0%
This company
38.2%
Market median
+146% vs market
2021
2025
Return on equity
23.7%
This company
18.4%
Market median
+29% vs market
2021
2025
Net profit margin
19.7%
This company
8.1%
Market median
+143% vs market
2021
2025
Asset turnover
1.13×
This company
1.12×
Market median
+1% vs market
2021
2025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on CyberGene Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network